INAUROPHARMA Stock Latest News
Company AnnouncementsAurobindo Pharma expands into U.S. contract research with A1 Biochem acquisition1M ago
Company AnnouncementsAurobindo Pharma Wins USFDA Nod for First Inhaler, Targeting $301 Million Asthma Market1M ago
Company AnnouncementsAurobindo Pharma Injects $1 Million into New U.S. R&D Arm After A1 Biochem Deal1M ago- Company AnnouncementsAurobindo Pharma to Join ICICI Securities Investor Meeting on September 171M ago
Company AnnouncementsAurobindo Pharma to Engage Investors at Kotak Healthcare Forum 20261M ago
Company AnnouncementsAurobindo Pharma’s Lannett Unit Completes Routine U.S. FDA Inspection With Procedural Observations2M ago
Company AnnouncementsAurobindo Pharma Wins FTC Nod for Lannett Acquisition, Eyes Month-End Closing4M ago
Company AnnouncementsAurobindo Pharma to Join Goldman Sachs Investor Meet in Hyderabad4M ago
Company AnnouncementsAurobindo Pharma Launches TheraNym Biologics Hub with MSD as Anchor Client5M ago
Company AnnouncementsUS FDA Flags Aurobindo’s Eugia Unit-I with OAI Classification5M ago
Company AnnouncementsAurobindo Pharma Replaces Secretarial Auditor After Health-Related Resignation5M ago
Company AnnouncementsAurobindo Pharma appoints new secretarial auditor after resignation of incumbent firm5M agoCompany AnnouncementsAurobindo Pharma’s Jedcherla Plant Cleared by US FDA With VAI Classification5M ago
Company AnnouncementsAurobindo Pharma Board Clears ₹800-Crore Share Buyback via Tender Offer6M ago
Company AnnouncementsAurobindo Pharma Transfers Domestic Branded Generics Business to Subsidiary6M ago- Company AnnouncementsAurobindo Pharma Clears ₹800-Crore Share Buyback at ₹1,475 a Share6M ago
- Company AnnouncementsAurobindo Pharma Schedules Analyst and Investor Plant Visit to Vizag and Kakinada7M ago
Company AnnouncementsAurobindo Pharma Schedules Analyst and Investor Plant Visit to Vizag and Kakinada7M agoCompany AnnouncementsAurobindo Pharma to Join Goldman Sachs India Pharma Corporate Days Investor Meet8M ago
Company AnnouncementsAurobindo Pharma Says Share Volume Surge Is Market-Driven Amid MIP Notification on Key Antibiotics9M ago